Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent and recurrent hyperparathyroidism.

Nadine R Caron1, Cord Sturgeon, Orlo H Clark

  • 1Department of Surgery, University of California San Francisco and UCSF Comprehensive Cancer Center at Mount Zion, 1600 Divisadero Street, Hellman Building, Room C3-47, San Francisco, CA 94143, USA.

Current Treatment Options in Oncology
|July 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forced resilience: Indigenous perspectives on systemic barriers and humanizing genomic medicine in British Columbia, Canada.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Towards the implementation of Indigenous data governance in neurogenomics research.

Nature neuroscience·2025
Same author

The cost and cost trajectory of genome sequencing and bioinformatics analysis for Indigenous children with suspected rare diseases.

Genetics in medicine : official journal of the American College of Medical Genetics·2025
Same author

The Financial Burden of Cancer in the United States.

Endocrinology and metabolism clinics of North America·2025
Same author

NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Great Debate: Molecular Testing and Extent of Surgery in Well-Differentiated Thyroid Cancer.

Annals of surgical oncology·2025
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Persistent and recurrent primary hyperparathyroidism (HPT) are challenging. Successful first surgery is the best treatment, preventing future HPT complications and ensuring patient cure.

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Medical Diagnostics

Background:

  • Primary hyperparathyroidism (HPT) has a high cure rate with initial surgery.
  • Persistent and recurrent HPT present significant clinical challenges.
  • Preventing treatment failure in HPT is crucial for patient outcomes.

Purpose of the Study:

  • To analyze factors contributing to persistent and recurrent HPT.
  • To guide the planning of surgical approaches for reoperative HPT.
  • To emphasize the importance of successful initial parathyroidectomy.

Main Methods:

  • Review of factors causing treatment failure: surgical, anatomical, and biological.
  • Evaluation of previous operative, pathology, and radiology reports.
  • Utilizing noninvasive and invasive localization procedures (ultrasound, sestamibi, MRI, selective venous sampling).

Related Experiment Videos

Main Results:

  • Repeat parathyroid exploration has higher complication rates and lower cure rates than initial surgery.
  • Intraoperative parathyroid hormone assays aid repeat dissections.
  • Parathyroidectomy is the only curative treatment for persistent/recurrent HPT.

Conclusions:

  • Understanding treatment failure factors is key to preventing persistent/recurrent HPT.
  • Expert preoperative localization and intraoperative tools are vital for repeat surgery.
  • Parathyroidectomy should be considered the first-line treatment for HPT.